F-D-C Strategy
I spoke with an F-D-C representative today who told me that all their newsletter titles have been pulled from LexisNexis as well. When I asked if they would make anything available through a third party distributor, she said, “Yes, the Web.” Somehow, that’s not what I meant by a third party distributor. F-D-C is banking on pay per view at their Web site rather than traditional online. I tried to clarify what I meant by asking if there was any place where F-D-C content was aggregated with other publications. Not in full text, she said, but they’re indexed in Pharmaceutical News Index. That’s a ProQuest database, available through Ovid, Dialog, and ProQuest itself. But searching an index database, logging off, going to the F-D-C site, and trying to find what you located in the index database is cumbersome and likely not to result in comprehensive results. It may, however, represent what information professionals will increasingly face in the future.